No abstract available
MeSH terms
-
Adenine / administration & dosage
-
Adenine / adverse effects
-
Adenine / analogs & derivatives*
-
Adenine / therapeutic use
-
Adult
-
Alkynes
-
Anti-HIV Agents / administration & dosage
-
Anti-HIV Agents / adverse effects*
-
Anti-HIV Agents / therapeutic use
-
Antiretroviral Therapy, Highly Active
-
Asthenia / chemically induced
-
Benzoxazines / administration & dosage
-
Benzoxazines / therapeutic use
-
Cyclopropanes
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives
-
Deoxycytidine / therapeutic use
-
Dideoxynucleosides / administration & dosage
-
Dideoxynucleosides / therapeutic use
-
Drug Eruptions / etiology
-
Drug Hypersensitivity / etiology*
-
Drug Substitution
-
Emtricitabine
-
Female
-
Fever / chemically induced
-
HIV Infections / complications
-
HIV Infections / drug therapy*
-
Humans
-
Lamivudine / administration & dosage
-
Lamivudine / therapeutic use
-
Nevirapine / administration & dosage
-
Nevirapine / therapeutic use
-
Organophosphonates / administration & dosage
-
Organophosphonates / adverse effects*
-
Organophosphonates / therapeutic use
-
Reverse Transcriptase Inhibitors / administration & dosage
-
Reverse Transcriptase Inhibitors / adverse effects*
-
Reverse Transcriptase Inhibitors / therapeutic use
-
Syndrome
-
Tenofovir
Substances
-
Alkynes
-
Anti-HIV Agents
-
Benzoxazines
-
Cyclopropanes
-
Dideoxynucleosides
-
Organophosphonates
-
Reverse Transcriptase Inhibitors
-
Deoxycytidine
-
Lamivudine
-
Nevirapine
-
Tenofovir
-
Emtricitabine
-
Adenine
-
efavirenz
-
abacavir